logo

X4 Pharmaceuticals Inc (XFOR) Stock: Uncovering 52-Week Market Trends

CSCO Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. X4 Pharmaceuticals Inc’s current trading price is -49.90% away from its 52-week high, while its distance from the 52-week low is 125.41%. The stock’s price range during this period has varied between $0.57 and $2.58. The company, active in the Healthcare sector, saw a trading volume of around 3.45 million for the day, considerably higher average daily volume of 2.13 million observed over the last three months.

X4 Pharmaceuticals Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $2.58 on 06/13/23, and the lowest price during that time was $0.57, recorded on 12/12/23.

How Financial Performance Impacts Market Capitalization

X4 Pharmaceuticals Inc (XFOR) has experienced a quarterly rise of 63.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 216.64M and boasts a workforce of 93 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9051, with a change in price of +0.5397. Similarly, X4 Pharmaceuticals Inc recorded 2,327,124 in trading volume during the last 100 days, posting a change of +71.93%.

How XFOR’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for XFOR stands at 1.14. Similarly, the long-term debt-to-equity ratio is also 1.12.

XFOR Stock Stochastic Average

As of today, the raw stochastic average of X4 Pharmaceuticals Inc over the last 50 days is at 64.02%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 60.26%. Further, the company’s Stochastic %K and %D values for the last 20 days were 71.37% and 76.64%, respectively.

XFOR Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 53.85% this year. Over the last six months, there has been a weaker performance of 36.78%. The price of XFOR fallen by 40.72% during the last 30 days period. For the last 5-days stocks have slided -8.51%.